Food intake and the presystemic metabolism of single doses of amitriptyline and nortriptyline

Fundamental and Clinical Pharmacology

Volumn 12, Issue 6, 1998, Pages 636-642

  Liedholm, H ^a   Liden A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amitriptyline; Bioavailability; Food intake; Nortriptyline; Presystemic metabolism

Indexed keywords

AMITRIPTYLINE; NORTRIPTYLINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DEMETHYLATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG OXIDATION; FEMALE; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032299873     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1998.tb00998.x     Document Type: Article

References (27)

1. Aaes-Jorgensen T, Liedholm H, Melander A. Influence of food intake on the bioavailability of zuclopenthixol. Drug-Nutrient Interactions 1987 ; 5 : 157-60
2. Axelson JE, Chan GLY, Kirsten EB, Mason WE, Lauman RC, Kerr CR. Enhancement of the bioavailability of propafenone by food. Brit J Clin Pharmacol 1987 ; 23 : 735-41
3. Bendtsen L, Jensen R, Olsen J. A non-selective (amitriptyline). but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996 ; 61 : 285-90
4. Biggs JT, Holland NH, Chang SS, Hipps PP, Sherman WR. The electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasma. J Pharm Sci 1976 ; 65 : 261-8
5. Block JL, Giller H, Gray S, Jatlow P. Steady-stale plasma concentrations of cis-and trans-10-OH amitriptyline metabolites. Clin Pharmacol Ther 1982 ; 31 : 609-16
6. Bryson HM, Wilde MI. Amitripyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging 1996 ; 8 : 459-76
7. Burch JE, Hullin RP. Amitriptyline pharmacokinetics. A cross-over study with single doses of amitriptyline and nortriptyline. Psychopharmacology (Berl) 1981 ; 74 : 35-42
8. Byrne AJ, McNeil J, Harrison PM, Louis W, Tonkin AM, McLean AJ. Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions. Brit J Clin Pharmacol 1984 ; 17 (Suppl 1) : 45-50
9. Daneshmend TK, Roberts CJC. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drugs: A study with labetalol. Brit J Clin Pharmacol 1982 ; 14 : 73-8
10. Dollery CT, ed. Therapeutic Drugs, Vol 2, Edinburgh: Churchill Livingstone; 1991. p N129
11. Eija K, Tiina T, Pertti NJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996 ; 64 : 293-302
12. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C, A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arhtritis Rheum 1996 ; 39 : 1852-9
13. Liedholm H, Lidén A, Kroon A, Melander A, Wåhlin-Boll E. Pharmacokinetics of dixyrazine: Low bioavailability, improved by food intake. Drug-Nutrient Interactions 1985 ; 3 : 87-92
14. Liedholm H, Melander A. Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation. Clin Pharmacol Ther 1986 ; 40 : 29-36
15. Liedholm H. Influence of food on the absorption and presystemic metabolism of drugs, PhD dissertation. Lund: University of Lund: 1989
16. Liedholm H, Wåhlin-Boll K, Melander A. Mechanisms and variations in the food effect on propranolol bioavailability. Eur J Clin Pharmacol 1990 ; 38 : 469-75
17. McLean AJ, McNamara P, du Souich P, Gibaldi M, Lalka D. Food, splanchnic blood flow and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther 1978 ; 24 : 5-10
18. Melander A, Danielson K, Scherstén B, Wåhlin E. Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther 1977 ; 22 : 108-12
19. Melander A, McLean AJ. Influence of food intake on presystemic clearance of drugs. Clin Pharmacokinet 1983 ; 8 : 286-97
20. Melander A, Lalka D, McLean A. Influence of food on the presystemic metabolism of drugs. Pharmacol Ther 1988 ; 38 : 253-67
21. Salmonsson T. Food effects: regulatory consequences. In: Midha KK, Blume HH, eds. Bio-International. Bioavailability. Bioequivalence and Pharmacokinetics. Stuttgart: Medpharm Scientific Publishers; 1993. p 251-5
22. Svensson CK, Edwards DJ, Mauriello PM, Barde SH, Foster AC, Lane RA, Middleton Jr E, Lalka D. Effect of food on hepatic blood flow: Implications in the 'food effect' phenomenon. Clin Pharmacol Ther 1983 ; 34 : 316-23
23. Svensson CK, Mauriello PM, Barde SH, Foster AC, Middleton Jr F, Lalka D. Effect of carbohydrates on estimated hepatic blood flow. Clin Pharmacol Ther 1984 ; 35 : 660-5
24. Svensson CK, Cumella JC, Tronolone M, Middleton Jr E, Lalka D. Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin Pharmacol Ther 1985 ; 37 : 464-8
25. Wagner JD. Propranolol pooled Michaelis-Menten parameters and the effect of input rate on bioavailability. Clin Pharmacol Ther 1985 ; 37 : 481-7
26. Wahlén A, Westerlund D, Wåhlin-Boll E, Melander A. Influence of food intake on the bioavailability of zimeldine and its active metabolite, norzimeldine. Drug-Nutrient Interactions 1984 ; 2 : 175-81
27. Walle T, Fagan T, Walle KU, Oexmann M-J, Conradi EC, Gaffney TE. Food-induced increase in propranolol bioavailability -relationship to protein and effects on metabolites. Clin Pharmacol Ther 1981 ; 30 : 790-5